Comparing Serial Kardia 6L ECGs in a Leadless Pacemaker Patient: Unreadable vs. Unclassified, Non-Capture, and Circadian Threshold Variation

By ABC Farma Medical Team Published: April 20, 2026 Reading time: ~9 min
Clinical TL;DR In a 97%-RV-paced patient (Abbott Aveir VR), two Kardia 6L tracings taken ten days apart at the same early-morning hour tell very different stories. The first is a metronomic paced rhythm the Kardia algorithm simply could not classify. The second shows a device-reported rate below the programmed lower rate limit, irregular R-R intervals, and beat-to-beat morphology variability — a pattern compatible with intermittent loss of capture, possibly driven by circadian threshold elevation. The surface tracing is suggestive; the Merlin.net marker channel and automatic capture threshold trend are confirmatory.
Educational content for healthcare professionals. This article discusses a clinical scenario for teaching purposes. It is not medical advice and does not substitute for individualized device interrogation, cardiology consultation, or electrophysiology evaluation.

The clinical question

Question submitted

A 71-year-old male patient with an Abbott Aveir VR leadless pacemaker (implanted for complete heart block, chronic RV-pacing burden ~97%) has recorded two Kardia 6L ECG tracings ten days apart, both in the early morning. The first tracing (April 9, 2026, 05:01) was labeled Unreadable with no heart rate reported. The second tracing (April 19, 2026, 05:41) was labeled Unclassified with a heart rate of 50 bpm. Can you explain the difference between the two ECGs?

Answer

Both tracings are from the same patient, both recorded on a 6-lead Kardia device in the same early-morning window, both 30 seconds in duration. Despite the superficial similarity, the clinical content of the two strips differs meaningfully. The April 9 tracing represents a metronomic paced rhythm that the Kardia classifier could not categorize. The April 19 tracing shows a device-reported rate below the programmed lower rate limit, irregular R-R intervals, and beat-to-beat morphology variability — a pattern compatible with intermittent loss of capture, possibly driven by circadian threshold elevation. The sections below work through the labels, the baseline tracing, the findings on the second tracing, a side-by-side summary, and the differential diagnosis.

The clinical question, unpacked: what is meaningfully different between these two tracings, and does the difference warrant action?

Why Kardia labels paced ECGs "Unreadable" or "Unclassified"

Before interpreting either tracing, the on-device labels themselves need to be demoted as clinical signal. The AliveCor Kardia classifier runs on Lead I only and is trained predominantly on native narrow-QRS rhythms. Paced rhythms violate two core assumptions: the QRS is wide and non-sinus, and P-waves are often obscured or dissociated.

The practical implication in a pacemaker patient is:

Neither label is diagnostic. Both require the tracing to be read manually. For patients with pacemakers, the device-reported rate and the visible morphology across all six leads carry the clinical weight.

Reading Tracing A (April 9): the baseline paced picture

The dominant finding on the April 9 6L is uniformity. Every QRS is wide, the morphology is LBBB-like with a left-superior axis — deeply negative in leads II, III, and aVF, positive in I and aVL — which is the canonical signature of apical or septal RV pacing. R-R intervals are regular across the 30-second recording, and the visible rate on the strip is in the mid-60s, consistent with the patient's programmed base rate with modest sensor-driven augmentation.

The "Unreadable" label here is a classifier artifact, not a clinical finding. The tracing represents the patient's chronic paced baseline.

Reading Tracing B (April 19): three findings that travel together

The April 19 tracing differs from the baseline in three linked ways. None in isolation is pathognomonic; together they define a distinct clinical pattern.

1. Rate below the programmed lower rate limit

The device-reported rate is 50 bpm, and the strip visually confirms slower cycle lengths than the April 9 recording. For an Aveir VR typically programmed with a lower rate limit of 60 bpm (VVIR), a sustained rate of 50 bpm across a 30-second window cannot be explained by rate-responsive down-adjustment at rest — the lower rate limit should act as a floor.

2. Irregular R-R intervals

Lead II on pages 4 and 5 shows clear beat-to-beat variability: longer cycles followed by shorter cycles, without the metronomic regularity that characterizes consistent VVIR pacing at base rate. Pacing at a fixed sensor-indicated rate should not produce irregularly irregular R-R intervals in the absence of sensing, capture, or conduction abnormalities.

3. Beat-to-beat QRS morphology variability

Most complexes retain the expected paced morphology (wide, LBBB-like, superior axis). A subset, however, show a different initial QRS vector and narrower width in leads I and aVL, with a less deeply negative deflection in the inferior leads. These are morphologically compatible with either intrinsic conducted beats (implying transient recovery of AV conduction or a junctional escape), fusion beats (intrinsic activation colliding with paced activation), or pseudofusion (pacing spike falling on an already-initiated intrinsic beat).

Side-by-side summary

FeatureApril 9, 2026 (Tracing A)April 19, 2026 (Tracing B)
Kardia determinationUnreadableUnclassified
Device-reported rateNot reported50 bpm
Visible R-R regularityRegularIrregular, especially later in recording
Dominant QRS morphologyUniform paced (LBBB-like, superior axis)Paced morphology present, intermixed with narrower/differently-shaped complexes
Implied rhythmConsistent VVIR pacing at sensor/base ratePossible intermittent non-capture with escape and/or fusion beats

Differential diagnosis for the April 19 findings

In a chronically RV-paced patient with complete heart block as the original indication, the leading explanations for the April 19 pattern, in descending order of likelihood, are:

  1. Intermittent loss of capture with junctional or ventricular escape. Irregular wide complexes at a rate below the programmed floor, with interspersed narrower beats, fit this pattern best. Capture failure in the early-morning window is classical.
  2. Functional non-capture due to circadian capture threshold rise. Capture thresholds vary diurnally with vagal tone, cortisol, and sleep-state autonomic shifts, typically peaking between 03:00 and 07:00. A device programmed with a narrow safety margin above threshold can transiently fail to capture during this window and return to normal capture by mid-morning.
  3. Undersensing producing competitive pacing and pseudofusion. Accounts for morphology variability without requiring true capture failure, though less likely to produce a sustained reported rate of 50 bpm.
  4. Atrial arrhythmia with variable AV conduction. Less likely given complete heart block as the underlying substrate, but not excluded from a 6L alone if AV conduction has partially recovered.
  5. Sensor or programming issue. A reprogrammed lower rate limit or sensor malfunction can explain the rate but not the morphology variability.

What the surface tracing cannot tell you — and what device interrogation will

A Kardia 6L is a screening tool, not a confirmatory one. For this patient, the next step is not another surface recording but formal device interrogation focused on the 05:41 timestamp on April 19. Specifically:

Clinical relevance for the LBBAP upgrade discussion

In patients with high RV-pacing burden who are already being evaluated for upgrade to left bundle branch area pacing (LBBAP), evidence of intermittent non-capture represents a second, independent indication for intervention — distinct from the chronic remodeling and biomarker trajectories that typically drive the upgrade discussion. A patient who is both developing pacing-induced cardiomyopathy physiology and experiencing episodic capture reliability problems has more reason to move, and to move sooner, than a patient with remodeling alone.

Teaching points

Frequently asked questions

Why does Kardia label a paced ECG as "Unreadable" or "Unclassified"?

The Kardia on-device algorithm runs on Lead I and is trained on native narrow-QRS rhythms. Wide paced QRS complexes and obscured P-waves break its detection assumptions, so paced tracings default to "Unreadable" (no rate extracted) or "Unclassified" (rate extracted but rhythm does not match a trained class). In a pacemaker patient, neither label carries clinical weight.

What does an RV-paced QRS morphology look like on a Kardia 6L?

Apical or septal RV pacing produces a wide LBBB-like QRS with a left-superior axis: negative in II, III, and aVF, positive in I and aVL. When capture is consistent, the morphology is uniform beat-to-beat.

How do you recognize intermittent loss of capture on a 6L ECG?

Look for a reported rate below the programmed lower rate limit, pacing spikes not followed by the expected paced QRS, R-R irregularity in a previously regular paced rhythm, and intermixed narrower complexes representing escape or conducted beats.

Why would capture thresholds rise in the early morning?

Capture thresholds follow a circadian pattern driven by vagal tone, cortisol nadir, and sleep-state autonomic changes. Thresholds typically peak between 03:00 and 07:00. A device programmed with a narrow safety margin can transiently fail to capture in this window and recover spontaneously later.

When should a Kardia tracing trigger formal device interrogation?

When it shows a rate below the programmed lower rate limit, new rhythm irregularity in a previously paced-regular patient, visible non-captured pacing spikes, beat-to-beat morphology variability, or correlated symptoms such as presyncope.

References and further reading

Suggested literature

  • Reddy VY, Exner DV, Cantillon DJ, et al. Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker. N Engl J Med. 2015.
  • Khurshid S, Epstein AE, Verdino RJ, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm. 2014.
  • Vijayaraman P, Chung MK, Dandamudi G, et al. His Bundle Pacing: 2018 JACC Review. J Am Coll Cardiol. 2018.
  • Sharma PS, Naperkowski A, Bauch TD, et al. Permanent His Bundle Pacing for Cardiac Resynchronization Therapy in Patients With Heart Failure and Right Bundle Branch Block. Circ Arrhythm Electrophysiol. 2018.
  • AliveCor Kardia 6L clinician information and labeling (device-specific classifier limitations in paced rhythms).